HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 313.80
Day range
kr 300.60 - kr 322.20
Year range
kr 238.20 - kr 547.00
Market cap
9.54B SEK
Avg Volume
186.16K
P/E ratio
55.70
Dividend yield
-
Primary exchange
STO
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 227.56M | 46.12% |
Operating expense | 158.62M | 20.03% |
Net income | 36.39M | -46.86% |
Net profit margin | 15.99 | -63.63% |
Earnings per share | 1.64 | -39.55% |
EBITDA | 28.07M | 1,766.75% |
Effective tax rate | 26.66% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 415.52M | -23.91% |
Total assets | 2.40B | 9.43% |
Total liabilities | 245.96M | -1.84% |
Total equity | 2.16B | — |
Shares outstanding | 31.50M | — |
Price to book | 4.58 | — |
Return on assets | 1.76% | — |
Return on capital | 1.92% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 36.39M | -46.86% |
Cash from operations | 62.08M | 242.49% |
Cash from investing | -111.40M | -111.84% |
Cash from financing | -2.39M | 35.75% |
Net change in cash | -34.46M | 28.46% |
Free cash flow | -38.22M | -38.90% |
About
Founded
1998
Website
Employees
190
